Clinical Trial Update: Repeat Dose Study in Male Healthy Volunteer Smokers [Phase 1]

View source ↗

Summary

GlaxoSmithKline conducted a Phase 1 repeat-dose study in healthy male smoker volunteers; the trial has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED